Encompass Health (NYSE:EHC) Raised to “Buy” at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of Encompass Health (NYSE:EHC) from a hold rating to a buy rating in a research report report published on Saturday, ValuEngine reports.

A number of other brokerages have also recently weighed in on EHC. Bank of America upgraded Encompass Health to a buy rating in a research note on Friday, September 6th. Deutsche Bank assumed coverage on Encompass Health in a research note on Tuesday, September 17th. They issued a hold rating and a $70.00 price objective for the company. BMO Capital Markets assumed coverage on Encompass Health in a research note on Thursday, June 27th. They issued an outperform rating and a $72.00 price objective for the company. Finally, Raymond James reduced their price objective on Encompass Health from $80.00 to $75.00 and set an outperform rating for the company in a research note on Wednesday, July 31st. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Encompass Health presently has an average rating of Buy and a consensus price target of $74.60.

EHC stock opened at $67.35 on Friday. The business has a 50 day moving average price of $63.61 and a 200 day moving average price of $62.41. The stock has a market cap of $6.59 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 1.98 and a beta of 0.84. Encompass Health has a fifty-two week low of $56.74 and a fifty-two week high of $76.20. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 1.87.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, July 29th. The company reported $1.08 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.11. Encompass Health had a return on equity of 24.10% and a net margin of 7.01%. The company had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.13 billion. As a group, sell-side analysts anticipate that Encompass Health will post 3.81 EPS for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: Trading Ex-Dividend Strategy

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Focused Wealth Management Inc Sells 446 Shares of Merck & Co., Inc.
Focused Wealth Management Inc Sells 446 Shares of Merck & Co., Inc.
Focused Wealth Management Inc Grows Position in Vanguard Total Stock Market ETF
Focused Wealth Management Inc Grows Position in Vanguard Total Stock Market ETF
Synovus Financial Corp Has $91,000 Stake in Arthur J Gallagher & Co
Synovus Financial Corp Has $91,000 Stake in Arthur J Gallagher & Co
Apple Inc.  Stock Position Trimmed by Wright Investors Service Inc.
Apple Inc. Stock Position Trimmed by Wright Investors Service Inc.
Focused Wealth Management Inc Has $5.68 Million Stock Holdings in SPDR S&P Bank ETF
Focused Wealth Management Inc Has $5.68 Million Stock Holdings in SPDR S&P Bank ETF
HCA Healthcare Inc  Shares Bought by Synovus Financial Corp
HCA Healthcare Inc Shares Bought by Synovus Financial Corp


 
© 2006-2019 Zolmax.